Orion Oyj
Helsinki Stock Exchange:ORNBV.HE
Sector
Industries
Location
Market Cap
USD 11.15 B
Share Price
USD 79.36
Avg Daily Volume
222,092
Change (1 day)
1.30%
Change (1 year)
56.25%
Change (YTD)
78.26%
Orion Oyj Operating Cash Flow for the year ending December 31, 2023: USD 131.35 M
Orion Oyj Operating Cash Flow is USD 131.35 M for the year ending December 31, 2023, a -71.74% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Orion Oyj Operating Cash Flow for the year ending December 31, 2022 was USD 464.78 M, a 89.29% change year over year.
-
Orion Oyj Operating Cash Flow for the year ending December 31, 2021 was USD 245.54 M, a -32.80% change year over year.
-
Orion Oyj Operating Cash Flow for the year ending December 31, 2020 was USD 365.37 M, a 20.23% change year over year.
-
Orion Oyj Operating Cash Flow for the year ending December 31, 2019 was USD 303.90 M, a 15.00% change year over year.
StockViz
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 701.23
LLY
+16.80
2.46%
AbbVie Inc.
USD 206.69
ABBV
+2.01
0.98%
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Novartis AG
USD 123.29
NOVN.SW
+1.51
1.24%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novo Nordisk A/S
USD 50.97
NOVO-B.CO
+0.44
0.87%
Merck & Co., Inc.
USD 84.21
MRK
+1.45
1.75%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Amgen Inc.
USD 296.47
AMGN
+6.18
2.13%
Gilead Sciences, Inc.
USD 118.37
GILD
-0.65
-0.55%
Pfizer Inc.
USD 25.14
PFE
+0.03
0.12%
Sanofi
USD 99.43
SAN.PA
+2.12
2.18%
Vertex Pharmaceuticals Incorporated
USD 392.79
VRTX
+2.49
0.64%
Bristol-Myers Squibb Company
USD 48.44
BMY
+0.63
1.32%
Chugai Pharmaceutical Co., Ltd.
USD 42.42
4519.T
+0.95
2.29%